Dental anxiety is a complex phenomenon with physical, mental, and social aspects (1) . High levels of dental anxiety can cause patients to experience stress and refuse or delay treatment. This damages oral health and leads to worsening of oral diseases. Dental anxiety also interferes with successful treatment by causing increased perceptions of pain after treatment, thereby delaying optimal recovery (2) . The prevalence of dental anxiety in adult patients is approximately 20% (3), with 5%-7% of patients experiencing extremely high levels of dental anxiety (4) . SANTUCHI et al. (5) reported relatively high levels of dental anxiety in periodontal patients, which were associated with poor gingival status. Dental anxiety can be reduced with the use of injected or inhaled sedatives. However, such drugs entail a risk of side effects, including respiratory depression, gastrointestinal disorders, nausea, vomiting, and allergic reactions. Additionally, sedatives increase the cost of dental treatment, and the body takes a long time to absorb injected sedatives, so they are of limited use in clinical settings. Therefore, drug-free methods are increasingly being used to ameliorate tension and moderate dental anxiety during treatment (6) .
High dental anxiety is associated with oral health issues and avoidance of dental care, and it can lead to mental anxiety. In turn, poor oral health is associated with symptoms of depression. In one previous study (7) , five patients exhibited clinically significant symptoms of depression during dental visits, and antidepressant medication caused reduced saliva production, poor oral hygiene, and periodontal diseaserelated bacterial infection. Such physiological changes can lead to periodontal disease as a result of abnormal immune responses (8) . Thus, clinicians must be aware of psychological parameters in patients with dental anxiety.
Muscle relaxation therapy reduces the activity of the sympathetic nervous system when stimulated by psychological and physiological responses, resulting in low heart rate, low respiratory rate, and low blood pressure. In addition, it can effectively regulate the peripheral and central nervous systems, thereby lowering stress, anxiety, and depression levels, and thus is effective in treating several health problems (9) . In previous studies, Dental Anxiety Scale (DAS) scores were reported to be significantly lower in a group receiving progressive muscle relaxation therapy than in the corresponding control group (10) , and patients receiving muscle relaxation therapy reported that the dental anxiety relief persisted during the subsequent dental visit (11) . ARMFIELD et al. (12) also suggested that progressive muscle relaxation therapy enables successful management of dental anxiety.
The purpose of this study was to establish the basis of dental anxiety mitigation by progressive muscle relaxation therapy in patients with dental anxiety.
The present randomized controlled trial (Clinical Research Information Service trial registration number KCT0001648) investigated whether progressive muscle relaxation therapy could relieve dental anxiety, and if so, whether the anxiety-relieving effects of the therapy lasted for 3 months in periodontal patients. The primary outcome was relief from dental anxiety 3 months after commencement of the intervention, and the secondary outcomes were reductions in dental anxiety, symptoms of depression, blood pressure, heart rate, and salivary cortisol concentration, which are considered indicators of stress (13, 14) , at 4 wk and 3 months after intervention commencement.
Material and methods

Sample size calculation
Dental anxiety was set as the primary evaluation outcome for calculating sample size. Based on existing research (15), a two-sided a-value of 0.05, a power of 0.80, and an effect size of 0.72, a sample size of 31 was originally calculated as appropriate for intergroup comparison of mean anxiety scores. Based on an anticipated drop-out rate of up to 10%, 35 patients were enrolled in each group to ensure an adequate final sample size.
Participants
The present study was approved by the Institutional Review Board of The Catholic University of Korea. The participants were 70 patients who visited a dental clinic in Incheon, Republic of Korea, between 4 September 2015 and 30 January 2016 for periodontal treatment. The inclusion criteria were as follows: chronic periodontal disease; age 30-59 yr; consent to participate after being briefed on the purpose of the study; a DAS of ≥13 on the Corah dental anxiety scale (16) ; dental treatment planned for 5 wk or longer; one or more periodontal pockets ≥4 mm in depth; the absence of systemic diseases that could affect periodontal disease; sightedness; literacy; and the ability to understand the study and answer questions. Two patients who did not meet the inclusion criteria were excluded: one had a DAS of <13; and the other was unavailable for the collection of saliva samples between noon and 4 PM. Thus, 68 patients were ultimately included in this trial.
The patients were randomly assigned to either an intervention group or a control group (n = 34 per group). Two patients in the intervention group and three in the control group dropped out after intervention commencement because they could not visit the clinic at the required time for personal reasons. Thus, a total of 63 patients completed the trial (Fig. 1) . 
Study flow
All participants were briefed on the purposes and methods of the study before being assigned to one of the two groups by a third party using random number generation software. A piece of paper indicating the assigned group was inserted into a sealed envelope, and participants were asked to open one of the sealed envelopes in a predetermined order at their first visit. An evaluator performed all measurements without knowing the group allocation of any of the participants.
Dental anxiety levels were evaluated using a dental anxiety questionnaire (16) , and psychological changes were assessed using a depression questionnaire (17) . Participants were administered these questionnaires at baseline and at 4 wk and 3 months after intervention commencement. To evaluate salivary cortisol concentrations, unstimulated saliva samples were collected. Blood pressure and heart rate were also recorded. All evaluations were performed between 12 PM and 4 PM (18) , and visits were scheduled according to patient availability. The intervention group received progressive muscle relaxation therapy and oral health education once per wk for 4 wk, and the control group received oral health education only, also once per week for 4 wk.
When administering progressive muscle relaxation therapy, we adopted a program used to alleviate dental anxiety in patients at a psychiatric department of a university hospital in South Korea. This intervention program has been shown to relieve fear and stress (19) . Furthermore, it is easy to learn and practice, requires no special equipment, and can be delivered anywhere at any time. Participants are advised to wear comfortable clothing and asked to remove glasses and footwear. They are seated in a relaxed position on a comfortable chair in a quiet, dimly lit room and asked to listen to a voice delivered through a headset playing a recording of a progressive muscle relaxation therapy script. During the recording, the patients are asked to close their eyes, breathe deeply, and imagine peaceful scenery. They are then asked to progressively tense and relax different muscle groups throughout their body-from global to local muscles, including those in the hands, arms, face, neck, shoulders, abdomen, legs, and feet. This develops muscle awareness and gives patients the ability to differentiate between tensed and relaxed muscles (19) . Participants in the intervention and control groups received the same periodontal treatment and oral health education. In both groups, the education was administered by a single dental hygienist in a separate dental office.
When conducting the periodontal disease treatment, clinicians ensured that patients were able to manage their periodontal health effectively. In addition, patients were instructed on proper toothbrushing practices in order to ensure appropriate management of their periodontal health. Patients in the test group received progressive muscle relaxation therapy for 20 min and oral health education for 15 min. Intervention was administered once per week for a total of 4 wk (i.e. at baseline, and 1, 2, and 3 wk after intervention commencement). Periodontal treatment was performed with scaling once, and root planing was performed three times. A total of four sessions were performed once per week. Each week, periodontal treatment was performed after intervention.
During the first week, patients were informed about proper toothbrush selection, storage and replacement of toothbrushes, toothbrushing time, and the importance of toothbrushing. During week 2, a clinical specialist with over 10 yr of experience explained proper toothbrushing methods (i.e. the Bass, Rolling, and Watanabe methods) (20) . The patients then practiced these methods on a tooth model, and their mistakes were identified and corrected during that process. During week 3, the patients were informed about interdental care and instructed on the use of oral hygiene products relevant to their individual periodontal conditions. During week 4, they were again instructed on methods of toothbrushing and the use of oral hygiene products.
Evaluations
The primary evaluation was the change in dental anxiety level at 3 months after starting the intervention, and the secondary evaluations were the changes in depression, vital signs, and salivary cortisol levels at 3 months after beginning the intervention. The primary outcome was measured via the DAS developed by CORAH (16) , which is the most common measure for evaluating dental patient anxiety. It comprises four questions that describe risky and threatening situations during dental treatment. Each question is scored from 1 (not anxious at all) to 5 (terrified); thus, the total score ranges from 4 to 20. Patients with DAS scores of ≥13 are deemed to experience dental anxiety. Cronbach's a coefficient for this index in the current study was 0.83.
Symptoms of depression were evaluated using the Beck Depression Inventory (17) , which evaluates clinical symptoms of depression and comprises 21 questions, with responses to each question measured on a 4-point Likert scale (0-3). The total score ranges from 0 to 63, with higher scores indicating higher levels of depression. The associated Cronbach's a coefficient in the current study was 0.91.
Patients were prohibited from consuming food and caffeine, smoking, and brushing their teeth for 1 h before saliva collection. Saliva samples were collected between 12 PM and 4 PM (18) . Patients were instructed to rest in a comfortable position, without speaking, for 5 min before saliva was collected. To avoid mixing saliva with food residue or blood, patients were asked to gargle with cold water before collection. Once the mouth was thus naturally moistened, patients were asked to spit into polypropylene specimen containers. Saliva samples containing blood were excluded.
The saliva samples (2 ml) were stored at À20°C and transported to the testing laboratory while frozen, before analysis. The samples were evaluated using a high-sensitivity salivary cortisol ELISA (Salimetrics LLC, State College, PA, USA) (21) .
Blood pressure was measured using an automated blood pressure monitor (MX3; Omron, Tokyo, Japan). Patients were prohibited from consuming caffeinated food, undergoing intensive exercise, and smoking for 1 h before measurements were made. During measurements, patients were instructed to rest for at least 10 min, and then blood pressure was measured 3 min later and again 5 min after the first measurement. The average value of the two measurements was used for analysis. If the margin of error was ≥10 mmHg, the measurement was repeated and the average of the two values with the smallest margin of error was used for analysis (22) .
Periodontal status was measured at the initial examination. A gingival index is the most commonly utilized method for gauging gingival inflammation while evaluating periodontal status. In the present study, the gingival indices of the buccal, lingual, mesial, and distal surfaces of six teeth were scored on a 4-point scale ranging from 0 to 3 points (23) .
Using a Williams probe (Hu-Friedy, Chicago, IL, USA), periodontal pocket depth (PPD) was measured in millimeters from the gingival ridge to the bottom of the pocket at the following six sites around each tooth, except the third molar: the mesiobuccal, midbuccal, distobuccal, distolingual, midlingual, and mesiolingual sites. The largest PPD value measured for each site, for each tooth, was recorded, and the mean value of all teeth was used for the analysis (24) .
Gingival bleeding on probing (BOP) with a periodontal probe is considered a sign of gingivitis. In the present study, the six sites around each tooth for which PPD was measured were checked for bleeding 10-30 s after probing. Bleeding on probing was recorded for each tooth as either absent (0) or present (1), if even only one site showed bleeding. The number of teeth with gingival bleeding was calculated as a percentage of the total dentition to yield a BOP percentage (25) .
Data analysis
Data analysis was performed using SAS version 9.4 (SAS Institute, Cary, NC, USA). Summary statistics are presented as number (%) for categorical variables and as mean AE SD for continuous variables. Baseline characteristics, as well as the patients' clinical and psychological parameters, were compared using the Wilcoxon rank-sum test, the chi-square test, or Fisher's exact test. Baseline data were compared with data obtained at 4 wk and 3 months after intervention commencement using the paired t-test or Wilcoxon signed-rank test. To confirm the efficacy of the therapy, time-dependent changes in the two groups were compared using analysis of covariance. All participants registered in this randomized clinical trial were analyzed using the intention-to-treat (ITT) method. In cases of missing data, the last observation carried forward (LOCF) method was utilized. All values of P <0.05 were considered statistically significant.
Results
As shown in Table 1 , there was no significant difference in the mean age between the intervention group (42.4 yr) and the control group (43.2 yr). The overall proportion of women in the study was 73%, and there were no significant differences in education level or income between the two groups.
At baseline, there were no significant differences in the level of gingivitis, PPD, or BOP between the two groups, and there were no significant differences in the psychological parameters (dental anxiety or symptoms of depression) or physiological parameters (diastolic blood pressure, heart rate, or salivary cortisol levels) between the two groups, with the exception of systolic blood pressure, which was significantly higher in the intervention group.
As shown in Table 2 , in the intervention group, the mean DAS score decreased from 13.7 AE 0.2 at baseline to 9.9 AE 0.2 and 9.6 AE 0.2, respectively, at 4 wk and 3 months after intervention commencement. Four weeks after intervention commencement, the decrease in dental anxiety was significantly greater in the intervention group than in the control group (À3.8 vs. À0.9; P < 0.001). Three months after commencement of the intervention, the decrease in dental anxiety was still significantly greater in the intervention group than in the control group (À4.2 vs. À0.3; P < 0.001). These results indicate that in both groups, dental anxiety had lessened 4 wk after intervention commencement and that the effects of muscle relaxation therapy lasted for at least 3 months.
As shown in Fig. 2 , the decrease in depression symptoms was significantly greater in the intervention group than in the control group (À1.3 vs. +0.5; P < 0.001) at the 4 wk assessment, and 3 months after commencement of the intervention, the decrease was still significantly greater in the intervention group than in the control group (À2.2 vs. +1.0; P < 0.001).
The decrease in systolic blood pressure 4 wk after intervention commencement was significantly greater in the intervention group than in the control group (À11.0 vs. +3.2; P < 0.001), and 3 months after commencement of the intervention, the decrease was still significantly greater in the intervention group than in the control group (À11.9 vs. +4.5; P < 0.001). Data are presented as n (%) or mean AE SD. The P-values of significant differences between the groups were determined using the chi-square test, Fisher's exact test, the Student's t-test, or the Wilcoxon rank-sum test.
The decrease in diastolic blood pressure 4 wk after intervention commencement was significantly greater in the intervention group than in the control group (À6.5 vs. +1.7; P < 0.001), and 3 months after commencement of the intervention, the decrease was still significantly greater in the intervention group than in the control group (À7.4 vs. +0.5; P < 0.001).
The decrease in pulse rate 4 wk after intervention commencement was significantly greater in the intervention group than in the control group (À6.7 vs. +2.2; Table 2 Comparison of dental anxiety levels at 4 weeks and 3 months post-intervention Values are given as mean AE SD or mean difference (95% CI).
The P-values of significant differences between the groups were determined using the chi-square test, Fisher's exact test, the Student's ttest, or the Wilcoxon rank-sum test.DAS, dental anxiety scale.Statistical analysis was performed by analysis of covariance, adjusted in accordance with the baseline value of each parameter. The P-values of significant differences in parameters between baseline and 4 wk or 3 months post-intervention were determined using the paired t-test or Wilcoxon signed-rank test. *Primary outcome. † Secondary outcome. DAS, dental anxiety scale. Fig. 2 . Comparisons of depression levels (A), systolic (B) and diastolic (C) blood pressure, pulse rate (D), and salivary cortisol levels (E) in the intervention and control groups at 4 wk and 3 months after the intervention. f/u, follow up.
P < 0.001), and 3 months after commencement of the intervention, the decrease was still significantly greater in the intervention group than in the control group (À7.3 vs. +0.1; P = 0.002). The decrease in salivary cortisol levels 4 wk after intervention commencement was significantly greater in the intervention group than in the control group (À1.0 vs. À0.1; P = 0.007), and 3 months after commencement of the intervention, the decrease was still significantly greater in the intervention group than in the control group (À1.0 vs. +0.3; P = 0.002).
These results indicate that in both groups, dental anxiety, depression symptoms, systolic blood pressure, diastolic blood pressure, pulse rate, and salivary cortisol levels had become reduced 4 wk after intervention commencement and that the effects of muscle relaxation therapy lasted for at least 3 months.
Discussion
The present study examined the effects of progressive muscle relaxation therapy on periodontal patients' dental anxiety relief maintenance at 4 wk and 3 months after intervention, and clearly demonstrated an association between progressive muscle relaxation therapy and the relief of dental anxiety. This result is consistent with that of a previous study which reported a significant decrease in anxiety in fracture patients who received progressive muscle relaxation therapy every morning and afternoon during hospitalization (13) . The findings are also concordant with those of another study in which there was a significant reduction in anxiety in patients with cancer who received therapy for 10 wk (26) .
Patients in the control group who did not receive progressive muscle relaxation therapy also experienced a temporary decrease in dental anxiety at 4 wk postintervention. However, at 3 months post-intervention, dental anxiety levels in the control group had increased again; by contrast, patients in the intervention group continued to experience dental anxiety relief, which indicated the effectiveness of progressive muscle relaxation therapy. The effects of therapy were observed to have lasted until 3 months post-intervention. On the basis of these findings, it may be concluded that progressive muscle relaxation therapy administered on a long-term basis under constant monitoring to ensure moderation produces long-lasting positive effects. We have found that the progressive muscle relaxation response can facilitate stress relief in patients with dental anxiety. The DAS is an objective, reliable, and validated measure that is widely used in adult dental anxiety research worldwide. It evaluates dental anxiety using specific questions about the respondent's dental situation. The original study conducted by CORAH (16) demonstrated that the internal consistency of the dental anxiety questions was high (standardized Cronbach's a = 0.86), and therefore the scale can be considered as accurate. Psychological and pharmacological interventions are effective in reducing dental anxiety. However, studies have shown (27) that pharmacological intervention results in risk factors and adverse effects; notably, persistent dental anxiety relief has been found only from psychological interventions. Therefore, it is necessary to use psychological intervention to alleviate dental anxiety.
The intervention group also exhibited reductions in symptoms of depression 4 wk and 3 months after starting the intervention, which is consistent with the results of a previous study in which patients with atopic dermatitis exhibited a significant decrease in depression symptoms 1 month after receiving muscle relaxation therapy twice daily for 4 wk (28). These results suggest that progressive muscle relaxation therapy effectively alleviates depression stemming from dental anxiety. The authors of another study argued that depression symptoms are strongly associated with dental anxiety and that they have a stronger effect on particular types of anxiety (7) .
In patients who are extremely afraid of dental treatment, symptoms of depression are caused by a combination of subjective stress from past experiences and a negative emotional state. Participants treated using progressive muscle relaxation therapy appear to experience a positive emotional state repeatedly, which reduces dental anxiety, stabilizes patient behavior, and consequently ameliorates depression symptoms. Therefore, to reduce patients' dental anxiety, dentists should be mindful of various psychological factors, particularly symptoms of depression.
The intervention group in the present study exhibited a clinically significant decrease in salivary cortisol levels. This is concordant with a previous study in which patients with breast cancer exhibited lower cortisol levels after being administered therapy once per week for 10 wk, whereas a control group that did not receive relaxation therapy exhibited an increase in cortisol levels (29) . In the present study, because the two groups had similar gingival states and demographic characteristics, neither of these factors could have affected the variables evaluated. Therefore, progressive muscle relaxation therapy can effectively reduce stress and it appears to alleviate dental anxiety and help patients feel relaxed and calm, leading to decreased cortisol levels.
There was a low drop-out rate in the present study (2.9%), and the LOCF method was used in cases of missing data, for ITT analysis. Nevertheless, outcomes did not differ between the ITT analyses with and without the missing variables, perhaps because the study used randomized allocation to prevent undue influence by a third confounding factor and to minimize prejudice or bias, ensuring an objective and scientific approach toward evaluating the effect of progressive muscle relaxation therapy on dental anxiety.
The present study had several limitations. Because the participants were enrolled from a single dental clinic, the generalizability of the intervention group, and consequently the external validity of the findings, may be limited. Psychological parameters, including dental anxiety, were evaluated using self-reported questionnaires and may therefore have been subjective. However, physiological indicators of anxiety, such as blood pressure, heart rate, and salivary cortisol levels, were objective. Studies involving longer follow-up periods are required to determine the duration of the effects of progressive muscle relaxation therapy.
In the present study, the administration of progressive muscle relaxation therapy over four sessions by a dental hygienist effectively alleviated dental anxiety in periodontal patients for at least 3 months after the intervention. Progressive muscle relaxation therapy can be used to relieve dental anxiety and stress in periodontal patients.
